1. Volume 70, Issue 5, Pages 808-815 (November 2016)
Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer 
Yi Lian, Hui Yin, Michael N. Pollak, Serge Carrier, Robert W. Platt, Samy Suissa, Laurent Azoulay 
European Urology 
Volume 70, Issue 5, Pages (November 2016)
DOI: /j.eururo
Copyright © Terms and Conditions

2. Fig. 1
Study flow diagram describing the assembly of the erectile dysfunction cohort using the UK Clinical Practice Research Datalink.
ED=erectile dysfunction; PDE5-I=phosphodiesterase type 5 inhibitor.
European Urology  , DOI: ( /j.eururo )
Copyright © Terms and Conditions

3. Fig. 2
Forest plots summarizing the sensitivity analyses for melanoma skin cancer.
CI=confidence interval; HR=hazard ratio.
* Cohort restricted to patients with at least one health-seeking behavior (influenza vaccination, referral to colonoscopy and prostate-specific antigen testing) in the year before cohort entry.
European Urology  , DOI: ( /j.eururo )
Copyright © Terms and Conditions